These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 8084585

  • 1. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.
    Stolzenberg MC, Brugières L, Gardes M, Dessarps-Freichey F, Chompret A, Bressac B, Lenoir G, Bonaïti-Pellié C, Lemerle J, Feunteun J.
    Oncogene; 1994 Oct; 9(10):2799-804. PubMed ID: 8084585
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
    Srivastava S, Tong YA, Devadas K, Zou ZQ, Sykes VW, Chen Y, Blattner WA, Pirollo K, Chang EH.
    Oncogene; 1992 May; 7(5):987-91. PubMed ID: 1373881
    [Abstract] [Full Text] [Related]

  • 4. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.
    Verselis SJ, Rheinwald JG, Fraumeni JF, Li FP.
    Oncogene; 2000 Aug 31; 19(37):4230-5. PubMed ID: 10980596
    [Abstract] [Full Text] [Related]

  • 5. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
    Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel RR, Dalla-Pozza L, Symonds G.
    Cell Growth Differ; 1992 Nov 31; 3(11):839-46. PubMed ID: 1467311
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
    Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D.
    Cancer Res; 1994 Mar 01; 54(5):1298-304. PubMed ID: 8118819
    [Abstract] [Full Text] [Related]

  • 9. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
    Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 01; 13(8):1403-6. PubMed ID: 15298965
    [Abstract] [Full Text] [Related]

  • 10. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
    Law JC, Strong LC, Chidambaram A, Ferrell RE.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6385-7. PubMed ID: 1933902
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cancer risks from germ line tumor suppressor gene mutations.
    Frebourg T, Malkin D, Friend S.
    Princess Takamatsu Symp; 1991 Dec 01; 22():61-70. PubMed ID: 1844252
    [Abstract] [Full Text] [Related]

  • 13. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
    Quesnel S, Verselis S, Portwine C, Garber J, White M, Feunteun J, Malkin D, Li FP.
    Oncogene; 1999 Jul 08; 18(27):3970-8. PubMed ID: 10435620
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53.
    Srivastava S, Wang S, Tong YA, Pirollo K, Chang EH.
    Oncogene; 1993 Sep 08; 8(9):2449-56. PubMed ID: 8361758
    [Abstract] [Full Text] [Related]

  • 17. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA.
    Cancer Res; 2003 Oct 15; 63(20):6643-50. PubMed ID: 14583457
    [Abstract] [Full Text] [Related]

  • 18. Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family.
    Varley JM, Chapman P, McGown G, Thorncroft M, White GR, Greaves MJ, Scott D, Spreadborough A, Tricker KJ, Birch JM, Evans DG, Reddel R, Camplejohn RS, Burn J, Boyle JM.
    Oncogene; 1998 Jun 25; 16(25):3291-8. PubMed ID: 9681828
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.